Sep 26, 2023
Dr. Narjust Florez, Dr. Fatima Wilder, Lauren Kiel, and Rebekah Kaufman underscore the need to comprehensively understand and address the unmet needs of young patients with lung cancer.
Aug 25, 2023
Ensuring Evidence-Based Medicine Is Reflected in Coding and Reimbursement: An Update From ASCO’s Advisor to the AMA CPT Editorial Panel
Dr. Joseph Merchant introduces the CPT process and recognizes ASCO colleagues who have represented the interests of members on this issue.
Aug 23, 2023
What to Expect After Submitting Your Fellowship Application: Tips for Hematology-Oncology Fellowship Application From Current Fellows
HemOncFellows Network organized an online discussion to address the common questions that hematology-oncology fellowship applicants have after submitting their fellowship application.
Aug 17, 2023
Advanced Practice Providers (APPs) Are Essential to Continuity of Cancer Care, Especially in Rural Communities
"Oncologists and APPs working together have the opportunity to increase practice volume, improve access to care, and ensure continuity for the patient," said Whitney Pritham.
Subscribe to this column
ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.
Nov 12, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. During the past six weeks I’ve had the opportunity to attend cancer meetings in four countries on three continents. In September, I represented ASCO at the annual meeting of the Chinese Society of Clinical Oncology (CSCO) in Xiamen,...
Feb 06, 2014
Meaningful Progress Against Gastric, Pancreatic, and Colorectal Cancers Reported at the 2014 Gastrointestinal Cancers Symposium
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. I’ve been a regular attendee of the Gastrointestinal Cancers Symposium since it began 11 years ago. This year’s meeting was among the very best with record attendance, superb educational talks and keynote lectures, multidisciplinary...